Acute renal failure after living-related liver transplantation.

Between June 1994 and November 2001, 87 patients underwent living-related liver transplantation at our hospital. Forty-seven of the patients were men and 40 women, with a mean age ( standard deviation) at the time of transplantation of 13.0 18.7 years. The 87 recipients presented with the following indications: biliary atresia (n 53), hepatitis B-related liver cirrhosis (n 8), hepatitis B-related liver cirrhosis with hepatocellular carcinoma (n 6), glycogen storage disease (n 5), primary biliary cirrhosis (n 5), neonatal hepatitis (n 6), hepatitis C-related liver cirrhosis (n 2), alagille (n 1), and Wilson’s disease (n 1). The donors included 43 mothers, 18 fathers, 9 wives, 6 sons, 3 aunts, 3 husbands, 2 grandmothers, 1 grandfather, 1 brother, and 1 daughter. Seventy-five patients received triple drug immunosuppression consisting of cyclosporin (CsA), azathioprine, and steroids and 12, a combination of tacrolimus (FK506) and steroids. All data are presented as mean SD.